1 / 33

Consumer Staples Company Presentation

Consumer Staples Company Presentation. Chad Hackett Adam Gale. Consumer Staples Analysis. + Dividends, Dividend yield is higher than S&P 500 - Earnings are declining relative to S&P 500 - Growing economy – Sector performs poorly during growth relative to S&P 500.

booker
Download Presentation

Consumer Staples Company Presentation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Consumer Staples Company Presentation Chad Hackett Adam Gale

  2. Consumer Staples Analysis • + Dividends, Dividend yield is higher than S&P 500 • - Earnings are declining relative to S&P 500 • - Growing economy – Sector performs poorly during growth relative to S&P 500

  3. Consumer Staples Composition SIM Companies • Procter & Gamble, 4.20% (Household Products) • Walgreens, 2.11% (Retail Drugs) • Anheuser-Busch, 3.94% (Beverage - Alcoholic)

  4. Procter & Gamble

  5. Business Analysis • Businesses • Baby, feminine & family care • Fabric & home care • Health care • Beauty care • Food & beverage • Main Brands • Pampers, Always • Tide, Bounty, Downy • Crest, Pepto Bismol • Cover Girl, Pantene, Herbal Essences • Folgers, Pringles

  6. Business: Demand • Expected EPS for 2005 : $2.59 • 11% increase from 2004 • Solid marketing and product innovation skills • Established brand recognition both domestic and international • Constant demand for P&G products

  7. Business: Supply • P&G’s growth for the future relies on foreign acquisitions and internal expansion overseas • i.e. Wella AG acquisition in 2003 • India and China remain strong growth drivers • Increased business in health and beauty-care by purchasing Clairol

  8. Financial: DuPont Analysis

  9. Valuation Analysis

  10. Valuation Analysis

  11. Recommendation • Hold Procter & Gamble. • Remaining a strong player in the consumer staples sector • Internal growth abroad • Foreign market expansion through acquisition William Proctor – 1837 James Gamble - 1837

  12. Anheuser-Busch

  13. Business Analysis • Businesses: • Domestic and International Beer • Packaging • Theme Parks • Main Products • Budweiser • Michelob • Busch • Natural Light

  14. Business: Demand • Consumption is up .8% from 2003 • International growth has contributed to at least 20% of A-B’s earnings over the past five years • Anheuser-Busch and Tsingtao Close China Investment Agreement • Increased profits in China by 45% • Demographics – Growth of the 21 to 27 year old age group • Inelastic demand for alcohol in general

  15. Financial: DuPont Analysis

  16. Valuation Analysis

  17. Valuation Analysis

  18. Recommendation • Sell Anheuser-Busch • Issues • Revenues shrinking from year to year • Pre-tax margins at all-time high, but price to sales and price to earnings at median levels • Hugely competitive market with Miller, other brewers

  19. Sysco Corporation

  20. Business Analysis • Businesses: • Food distributor • Supply distributor (plates, silverware, etc • Main Customers • Restaurants • Health-care facilities • Education facilities

  21. Business: Demand • Revenue is increasing from year-to-year • Expected increase in the number of people in healthcare facilities • Growing economy stimulates consumer spending (dining out)

  22. Financial: DuPont Analysis

  23. Valuation Analysis

  24. Valuation Analysis

  25. Recommendation • Buy Sysco Corporation • Reasons • Growth rate estimates at an all-time high relative to consumer staples sector • Price-to-earnings and price-to-sales do not reflect this expectation • Certain demand increases via healthcare and increased discretionary consumer spending

  26. CVS versus Walgreen Corporation

  27. CVS versus Walgreen Business • Walgreen currently largest U.S. Retail Drug Store with 37.5 billion dollars in sales • CVS is second with 22.6 billion dollars in sales

  28. Demand • Increased need for prescription drugs as population continues to grow older • Continued expansion in opening of new stores for both companies • CVS through acquisition (Eckerd from J.C. Penny)

  29. Dupont - CVS

  30. Dupont - Walgreen

  31. Valuation – CVS versus Walgreens

  32. Recommendation • Sell Walgreen Corporation to acquire CVS • More potential for growth in 2005 • Retail drug market is expanding • Large acquisition of Eckerd will be more beneficial in 2005 • Walgreen Corporation above industry ratios

  33. Questions

More Related